SQUAWK/NEWS
Menu
Live News EQUITY L impact

Cadrenal Therapeutics Files SEC Form

Cadrenal Therapeutics submits regulatory filing with SEC

CRNL

Filed: 2026-05-26 AccNo: 0001213900-26-061167 Size: 6 KB